Importance: Asthma is the most common chronic childhood disease, with Black children experiencing worse morbidity and mortality. It is important to evaluate the effectiveness of efficacious interventions in community settings that have the greatest likelihood of serving at-risk families. Objective: To evaluate the effectiveness of a multilevel home- and school (Head Start)-based asthma educational program compared with a Head Start-based asthma educational program alone in improving asthma outcomes in children. Design, Setting, and Participant: This randomized clinical trial included 398 children with asthma enrolled in Head Start preschool programs in Baltimore, Maryland, and their primary caregivers. Participants were recruited from April 1, 2011, to November 31, 2016, with final data collection ending December 31, 2017. Data were analyzed from March 18 to August 30, 2018. Interventions: Asthma Basic Care (ABC) family education combined with Head Start asthma education compared with Head Start asthma education alone. Main Outcomes and Measures: Asthma control as measured by the Test for Respiratory and Asthma Control in Kids (TRACK) score. Results: Among the 398 children included in the analysis (247 boys [62.1%]; mean [SD] age, 4.2 [0.7] years), the ABC plus Head Start program improved asthma control (β = 6.26; 95% CI, 1.77 to 10.75; P < .001), reduced courses of oral corticosteroids (β = -0.61; 95% CI, -1.13 to -0.09; P = .02), and reduced hospitalizations (odds ratio, 0.36; 95% CI, 0.21-0.61; P < .001) during a 12-month period. Conclusion and Relevance: In this randomized clinical trial, combined family and preschool asthma educational interventions improved asthma control and reduced courses of oral corticosteroids and hospitalizations. Multilevel interventions implemented in community settings that serve low-income minority families may be key to reducing disparities in asthma outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT01519453.
Importance: Asthma is the most common chronic childhood disease, with Black children experiencing worse morbidity and mortality. It is important to evaluate the effectiveness of efficacious interventions in community settings that have the greatest likelihood of serving at-risk families. Objective: To evaluate the effectiveness of a multilevel home- and school (Head Start)-based asthma educational program compared with a Head Start-based asthma educational program alone in improving asthma outcomes in children. Design, Setting, and Participant: This randomized clinical trial included 398 children with asthma enrolled in Head Start preschool programs in Baltimore, Maryland, and their primary caregivers. Participants were recruited from April 1, 2011, to November 31, 2016, with final data collection ending December 31, 2017. Data were analyzed from March 18 to August 30, 2018. Interventions: Asthma Basic Care (ABC) family education combined with Head Start asthma education compared with Head Start asthma education alone. Main Outcomes and Measures: Asthma control as measured by the Test for Respiratory and Asthma Control in Kids (TRACK) score. Results: Among the 398 children included in the analysis (247 boys [62.1%]; mean [SD] age, 4.2 [0.7] years), the ABC plus Head Start program improved asthma control (β = 6.26; 95% CI, 1.77 to 10.75; P < .001), reduced courses of oral corticosteroids (β = -0.61; 95% CI, -1.13 to -0.09; P = .02), and reduced hospitalizations (odds ratio, 0.36; 95% CI, 0.21-0.61; P < .001) during a 12-month period. Conclusion and Relevance: In this randomized clinical trial, combined family and preschool asthma educational interventions improved asthma control and reduced courses of oral corticosteroids and hospitalizations. Multilevel interventions implemented in community settings that serve low-income minority families may be key to reducing disparities in asthma outcomes. Trial Registration: ClinicalTrials.gov Identifier: NCT01519453.
Authors: Diana M Tisnado; John L Adams; Honghu Liu; Cheryl L Damberg; Wen-Pin Chen; Fang Ashlee Hu; David M Carlisle; Carol M Mangione; Katherine L Kahn Journal: Med Care Date: 2006-02 Impact factor: 2.983
Authors: Michelle Boyd; Toby J Lasserson; Michael C McKean; Peter G Gibson; Francine M Ducharme; Michelle Haby Journal: Cochrane Database Syst Rev Date: 2009-04-15
Authors: Robert S Zeiger; Michael Mellon; Bradley Chipps; Kevin R Murphy; Michael Schatz; Mark Kosinski; Kathy Lampl; Sulabha Ramachandran Journal: J Allergy Clin Immunol Date: 2011-09-08 Impact factor: 10.793
Authors: Jennifer A Callaghan-Koru; Kristin A Riekert; Elizabeth Ruvalcaba; Cynthia S Rand; Michelle N Eakin Journal: Pediatrics Date: 2018-08-07 Impact factor: 7.124
Authors: Hatice S Zahran; Cathy M Bailey; Scott A Damon; Paul L Garbe; Patrick N Breysse Journal: MMWR Morb Mortal Wkly Rep Date: 2018-02-09 Impact factor: 17.586
Authors: Monica A Lu; Thomas Eckmann; Elizabeth Ruvalcaba; Elizabeth L McQuaid; Cynthia S Rand; Kristin A Riekert; Michelle N Eakin Journal: Ann Allergy Asthma Immunol Date: 2021-11-10 Impact factor: 6.347